Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2020 08:35 ET | Source: Aeterna Zentaris Inc

Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update

– Pivotal Phase 3 safety and efficacy study AEZS-130-P02 (“Study P02”) expected to commence in Q1 2021 – Continue to advance discussions to secure a commercialization partner for macimorelin in...